Neogen Chemicals Limited

BSE: NEOGEN542665ISIN INE136S01016

Commodities
Specialty Chemicals
BSE 1000

Share price

₹2,268.40+89.10 (+4.09%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹2,785.00
52W low: ₹978.00
Off 52W high: -18.55%
1M return: -1.91%
3M return: +12.68%
6M return: +33.80%
1Y return: +54.05%
20D avg volume: 14,259
50 DMA: ₹2,314.23
200 DMA: ₹1,831.84

Key ratios Consolidated

Market cap: ₹6,815 Cr
Current price: ₹2,268.40
52W high / low: ₹2,785.00 / ₹978.00
Face value: ₹10.00
P/E: 168.60
P/B: 4.32
EPS (TTM): ₹13.45
Book value / share: ₹525.49
ROE: —
ROCE: 6.80%
Operating margin: —
Net margin: —
Debt / equity: 1.63
Net debt: ₹1,325 Cr
Interest cover: 1.55
Dividend yield: 0.04%
Dividend / share (TTM): ₹1.00
Payout: 7.43%
Cash conversion cycle: 214.5 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	295.96	250.29	246.56	220.02	208.66	186.73	202.82	201.43	193.36	179.95	199.65	164.44
	3.96	3.86	0.98	2.09	1.89	1.18	0.59	1.06	0.79	1.57	2.21	1.58
	299.92	254.15	247.54	222.11	210.55	187.91	203.41	202.49	194.15	181.52	201.86	166.02
	287.20	231.07	231.69	216.46	205.49	173.67	185.70	187.32	178.72	165.78	179.41	160.41
	234.88	180.03	164.81	191.94	152.98	128.38	164.17	151.51	88.62	101.77	137.16	119.47
	0.00	0.74	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	30.96	25.30	20.20	26.02	24.29	19.57	18.31	15.69	14.83	16.01	14.76	16.73
	27.78	20.81	21.47	21.51	19.48	12.67	12.50	13.43	12.75	9.82	9.69	10.52
	8.79	8.20	7.60	6.83	7.31	5.78	6.76	7.10	7.12	6.81	5.86	5.74
	56.22	42.99	45.62	45.73	42.86	33.90	40.63	41.76	34.19	36.76	37.02	36.44
	12.72	23.08	15.85	5.65	5.06	14.24	17.71	15.17	15.43	15.74	22.45	5.61
	0.00	0.00	0.00	0.00	0.00	0.00	-14.08	0.00	0.00	0.00	0.00	0.00
	12.72	23.08	15.85	5.65	5.06	14.24	3.63	15.17	15.43	15.74	22.45	5.61
	4.49	6.17	4.46	2.07	1.78	4.03	1.27	5.24	4.52	4.29	5.54	4.64
	8.23	17.11	11.39	3.69	3.37	10.26	2.41	10.01	10.96	11.47	16.93	1.06
	2.96	6.29	4.32	1.40	1.28	3.89	0.91	3.80	4.15	4.35	6.42	0.41
Key metrics
	49.29	52.09	44.92	33.99	31.85	32.69	22.89	35.70	35.30	32.37	38.00	21.87
	16.70%	20.80%	18.20%	15.40%	15.30%	17.50%	11.30%	17.70%	18.30%	18.00%	19.00%	13.30%
	2.80%	6.80%	4.60%	1.70%	1.60%	5.50%	1.20%	5.00%	5.70%	6.40%	8.50%	0.60%
	1.60%	—	2.20%	—	1.70%	—	1.60%	—	—	—	—	—
	41.80%	34.00%	21.60%	9.20%	7.90%	3.80%	1.60%	22.50%	—	—	—	—
	144.20%	66.80%	372.60%	-63.10%	-69.30%	-10.50%	-85.80%	844.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,013	861.96	777.56	690.67	686.18	487.25
	10.89	6.14	4.01	7.47	4.45	1.07
	1,024	868.10	781.57	698.14	690.63	488.32
	966.42	827.02	717.53	645.55	619.70	431.43
	771.66	638.09	506.08	474.59	485.26	343.77
	0.74	0.00	0.00	—	—	—
	102.48	90.08	64.84	62.00	46.82	31.50
	91.57	75.11	48.50	42.06	28.94	19.08
	31.42	27.52	27.79	22.87	16.20	11.69
	190.56	167.86	153.34	136.13	139.23	94.19
	57.30	41.08	64.04	52.59	70.93	56.89
	0.00	0.00	-14.08	0.00	0.00	0.00
	57.30	41.08	49.96	52.59	70.93	56.89
	17.19	12.33	15.33	17.12	21.06	12.44
	40.42	28.75	34.83	35.65	49.97	44.63
	14.97	10.90	13.20	13.96	20.03	18.70
Key metrics
	180.29	143.71	126.25	117.52	116.07	87.66
	17.80%	16.70%	16.20%	17.00%	16.90%	18.00%
	3.99%	3.30%	4.50%	5.20%	7.30%	9.20%
	—	6.80%	9.70%	—	—	—
	26.66%	10.90%	12.60%	0.70%	40.80%	—
	55.16%	-17.50%	-2.30%	-28.70%	12.00%	—
	—	-787.16	-121.69	—	—	—
	—	-8.05	5.63	—	—	—
	—	1.63	0.72	—	—	—
	—	1,325	561.08	—	—	—
	—	214.5	115.6	—	—	—
Balance sheet
	—	2,902	1,747	—	—	—
	—	1,393	999.83	—	—	—
	—	4.94	4.96	—	—	—
	—	380.36	200.22	—	—	—
	—	568.23	309.13	—	—	—
	—	152.38	44.08	—	—	—
	—	474.16	373.64	—	—	—
	—	442.14	263.19	—	—	—
	—	1,188	733.40	—	—	—
	—	1,330	566.04	—	—	—
	—	510.74	395.94	—	—	—
	—	819.15	170.10	—	—	—
	—	816.25	789.39	—	—	—
Cash flow
	—	-231.48	195.98	—	—	—
	—	-410.25	-316.59	—	—	—
	—	641.71	113.07	—	—	—
	—	555.68	317.67	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	288.00	252.28	248.63	215.60	206.68	184.58	203.75	200.41	174.49	166.71	190.63	167.37
	8.28	7.90	3.87	4.26	4.37	3.31	2.65	2.05	2.08	2.92	3.59	1.48
	296.28	260.18	252.50	219.86	211.05	187.89	206.40	202.46	176.57	169.63	194.22	168.85
	267.85	234.05	232.58	208.06	198.72	168.81	185.09	182.41	159.12	153.01	170.99	156.63
	221.01	176.53	169.67	189.81	154.49	127.41	158.63	152.98	83.62	92.22	129.43	121.67
	16.84	7.49	0.00	1.59	0.00	0.00	0.00	—	—	—	—	—
	22.98	21.40	16.93	20.12	20.12	17.22	16.13	14.17	12.45	12.77	11.95	13.64
	26.55	23.10	22.95	22.85	20.60	14.03	16.50	13.07	11.72	9.01	9.44	10.03
	7.01	6.83	6.38	5.87	6.39	4.88	6.01	6.58	5.86	5.65	5.04	5.00
	44.22	39.48	42.21	42.41	39.83	31.38	37.81	39.91	31.53	34.75	34.08	35.58
	28.43	26.13	19.92	11.80	12.33	19.08	21.31	20.05	17.45	16.62	23.23	12.22
	0.00	0.00	0.00	0.00	0.00	0.00	-13.56	—	—	—	—	—
	28.43	26.13	19.92	11.80	12.33	19.08	7.75	20.05	17.45	16.62	23.23	12.22
	7.29	6.69	5.26	3.03	3.02	4.85	2.56	5.64	4.42	4.20	5.53	6.42
	21.14	19.44	14.66	8.77	9.31	14.23	5.19	14.41	13.03	12.42	17.70	5.80
	7.60	7.15	5.56	3.32	3.53	5.40	1.97	5.46	4.94	4.71	6.71	2.24
Key metrics
	61.99	56.06	49.25	40.52	39.32	37.99	30.26	39.70	35.03	31.28	37.71	27.25
	21.50%	22.20%	19.80%	18.80%	19.00%	20.60%	14.90%	19.80%	20.10%	18.80%	19.80%	16.30%
	7.30%	7.70%	5.90%	4.10%	4.50%	7.70%	2.50%	7.20%	7.50%	7.50%	9.30%	3.50%
	3.10%	—	3.70%	—	2.90%	—	2.70%	—	—	—	—	—
	39.30%	36.70%	22.00%	7.60%	18.40%	10.70%	6.90%	19.70%	—	—	—	—
	127.10%	36.60%	182.50%	-39.10%	-28.50%	14.60%	-70.70%	148.40%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,005	855.49	773.65	696.36	686.18	487.25
	24.31	15.82	9.76	8.78	4.63	1.34
	1,029	871.31	783.41	705.14	690.81	488.59
	942.54	808.18	703.49	641.50	619.70	431.43
	757.02	641.37	498.84	482.91	485.26	343.77
	25.92	1.59	0.00	—	—	—
	81.43	74.40	58.29	52.93	46.82	31.50
	95.45	80.42	51.38	40.83	28.94	19.08
	26.09	23.53	25.59	19.89	16.20	11.69
	168.32	155.84	145.71	130.91	139.23	94.19
	86.28	63.13	79.92	63.64	71.11	57.16
	0.00	0.00	-13.56	—	—	—
	86.28	63.13	66.36	63.64	71.11	57.16
	22.27	16.17	17.95	19.58	21.06	12.44
	64.01	46.96	48.41	44.06	50.05	44.72
	23.63	17.81	18.35	17.25	20.07	18.74
Key metrics
	207.82	167.08	143.33	124.36	116.25	87.93
	20.69%	19.50%	18.50%	17.90%	16.90%	18.00%
	6.37%	5.50%	6.30%	6.30%	7.30%	9.20%
	—	12.30%	12.90%	—	—	—
	26.29%	10.60%	11.10%	1.50%	40.80%	—
	48.38%	-3.00%	9.90%	-12.00%	11.90%	—
	—	-215.11	166.08	—	—	—
	—	-2.11	4.11	—	—	—
	—	0.79	0.55	—	—	—
	—	668.41	443.23	—	—	—
	—	207.3	118.0	—	—	—
Balance sheet
	—	2,176	1,621	—	—	—
	—	1,271	1,066	—	—	—
	—	3.04	0.48	—	—	—
	—	356.74	199.05	—	—	—
	—	551.65	306.21	—	—	—
	—	82.71	26.30	—	—	—
	—	293.87	197.80	—	—	—
	—	422.50	255.14	—	—	—
	—	1,011	707.09	—	—	—
	—	671.45	443.71	—	—	—
	—	442.47	395.95	—	—	—
	—	228.98	47.76	—	—	—
	—	853.80	808.85	—	—	—
Cash flow
	—	-99.20	198.76	—	—	—
	—	-35.16	-188.44	—	—	—
	—	136.92	-12.14	—	—	—
	—	115.91	32.68	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +7.63%
Sales CAGR 5Y: —
Profit CAGR 3Y: -2.10%
Profit CAGR 5Y: —
Sales YoY (TTM): +26.29%
Profit YoY (TTM): +48.38%

Consolidated

Sales CAGR 3Y: +7.90%
Sales CAGR 5Y: —
Profit CAGR 3Y: -16.83%
Profit CAGR 5Y: —
Sales YoY (TTM): +26.66%
Profit YoY (TTM): +55.16%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 48.29%

Quarter	September 2026	16 Sep 2026	04 Sep 2026	June 2026
Promoter %	48.29%	48.29%	52.99%	48.29%

Holder	Type	Holding	Previous	Change
Haridas Kanani Family Trust (Beena Haridas Kanani and Harin Haridas Kanani)	Promoter	17.56%	17.56%	0.00%
HARIN HARIDAS KANANI	Promoter	11.11%	11.11%	0.00%
Beena Kanani Family Trust (Haridas Thakarshi Kanani and Harin Haridas Kanani)	Promoter	8.78%	8.78%	0.00%
CADAMBA SOLUTIONS PRIVATE LIMITED	Promoter Group	4.49%	4.49%	0.00%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUND	Public	4.25%	4.18%	+0.07%
SBI CONTRA FUND	Public	4.16%	4.79%	-0.63%
PALLIKA HARIDAS KANANI	Promoter Group	3.32%	3.32%	0.00%
INVESCO INDIA ELSS TAX SAVER FUND	Public	1.92%	—	—
SBI LIFE INSURANCE CO. LTD	Public	1.68%	1.18%	+0.50%
H T Kanani Family Trust (Beena Haridas Kanani and Pallika Haridas Kanani)	Promoter Group	1.67%	1.67%	0.00%
MIRAE ASSET AGGRESSIVE HYBRID FUND	Public	1.61%	1.61%	0.00%
ICICI PRUDENTIAL COMMODITIES FUND	Public	1.35%	—	—
WHITEOAK CAPITAL MID CAP FUND	Public	1.34%	—	—
MALABAR INDIA FUND LIMITED	Public	1.30%	1.30%	0.00%
BEENA HARIDAS KANANI	Promoter Group	1.25%	1.25%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Pidilite Industries Ltd.	1,53,494	1,507.00	56.47	28.50%	+16.83% TTM	+20.94% TTM	+3.57%
Gujarat Fluorochemicals Limited	50,673	4,612.90	75.63	10.10%	+20.33% TTM	-1.47% TTM	+25.63%
Navin Fluorine International Limited	45,075	8,785.00	49.50	18.70%	+45.68% TTM	+105.04% TTM	+45.12%
Deepak Nitrite Limited	21,559	1,580.65	20.29	10.80%	+23.80% TTM	+99.83% TTM	-9.73%
Aether Industries Limited	20,478	1,542.85	82.16	12.20%	+30.76% TTM	+28.03% TTM	+103.85%
Aarti Industries Ltd	16,311	449.65	27.46	8.50%	+39.85% TTM	+104.40% TTM	+16.66%
Fine Organic Industries Limited	15,720	5,127.35	38.71	20.20%	+12.92% TTM	+18.80% TTM	+16.19%
Atul Limited.	15,177	5,155.00	19.28	13.50%	+18.15% TTM	+40.10% TTM	-12.49%
Anupam Rasayan India Limited	13,029	1,144.40	57.92	7.50%	+51.76% TTM	+14.65% TTM	+6.58%
PRIVI SPECIALITY CHEMICALS LIMITED	12,825	3,283.30	34.73	25.10%	+17.54% TTM	+44.15% TTM	+10.09%
BASF India Ltd	12,812	2,959.95	21.44	13.10%	+13.35% TTM	+59.30% TTM	-33.46%
Sudeep Pharma Limited	12,657	1,120.60	67.10	24.20%	—	—	—
Vinati Organics Ltd.	10,334	996.85	25.09	17.70%	+10.98% TTM	-5.48% TTM	-39.90%
Elantas Beck India Ltd S	10,127	12,774.65	54.20	—	+18.86% TTM	+35.25% TTM	+29.29%
Jubilant Ingrevia Limited	8,957	562.35	25.55	10.80%	+15.41% TTM	+21.73% TTM	-18.43%
Alkyl Amines Chemicals Ltd. S	8,108	1,585.25	32.77	14.60%	+13.38% TTM	+35.83% TTM	-13.31%
Galaxy Surfactants Limited	8,048	2,269.80	22.75	12.70%	+27.05% TTM	+16.13% TTM	+0.01%
Clean Science and Technology Limited	6,979	656.60	29.92	19.20%	+4.51% TTM	-12.06% TTM	-33.34%
Neogen Chemicals Limited	6,815	2,268.40	168.60	6.80%	+26.66% TTM	+55.16% TTM	+54.05%
Fineotex Chemical Limited	6,221	53.42	41.98	16.20%	+91.44% TTM	+41.07% TTM	+84.27%
Balaji Amines Ltd.	5,738	1,770.80	23.80	10.20%	+20.91% TTM	+66.05% TTM	+26.00%
Archean Chemical Industries Limited	5,291	428.60	54.04	7.80%	+5.99% TTM	-42.66% TTM	-34.05%
Prasol Chemicals Limited	4,594	776.20	—	—	—	—	—
Laxmi Organic Industries Limited	4,501	161.95	35.81	4.40%	+5.47% TTM	+25.01% TTM	-17.12%
Foseco India Ltd S	4,494	5,962.25	57.00	—	+10.33% TTM	-3.71% TTM	+5.42%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Intimation of Analyst/Investor Meeting to be held on November 17, 2026.4 Nov 2026 · Company Update / Analyst / Investor Meet
Monitoring agency report for the quarter ended September 30, 2026 i.r.o. QIP of Rs. 600 crores.3 Nov 2026 · Company Update / Monitoring Agency Report
Earnings call recording Q2 H1 FY 20272 Nov 2026 · Company Update / Analyst / Investor Meet
Earnings Presentation for the quarter and half year ended 30-09-20261 Nov 2026 · Company Update / Investor Presentation
Press Release for the Quarter and half year ended 30-09-2026.1 Nov 2026 · Company Update / Press Release / Media Release
Statement of Deviation and Variation w.r.t. QIP31 Oct 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Security cover certificate as on September 30, 202631 Oct 2026 · Others / Reg. 54 - Asset Cover details
Outcome of Board meeting held on Saturday, October 31, 202631 Oct 2026 · Company Update / General
Outcome of Board meeting held on Saturday, October 31, 202631 Oct 2026 · Company Update / General
Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 202631 Oct 2026 · Result / Financial Results
1) Unaudited Financial Results of the Company for the quarter and half year ended 30-09-2026 2) Statement of Deviation/Variation in utilization of funds for the quarter ended 30-09-2026 ....31 Oct 2026 · Board Meeting / Outcome of Board Meeting
Update on Insurance Claim30 Oct 2026 · Company Update / General
Update on Insurance Claim30 Oct 2026 · Company Update / Strikes /Lockouts / Disturbances
Intimation of earnings conference call scheduled to be held on Monday, November 2, 2026 at 5:00 p.m. for analysts/investors28 Oct 2026 · Company Update / Analyst / Investor Meet
Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve 1) Approval of unaudited standalone ....28 Oct 2026 · Board Meeting / Board Meeting
Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue basis.26 Sep 2026 · Company Update / General
Intimation of credit rating.26 Sep 2026 · Company Update / Credit Rating
Intimation of closure of trading window25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Analyst/Investor meet to be held on September 28, 2026.23 Sep 2026 · Company Update / Analyst / Investor Meet
Press Release titled " Neogen Chemicals raises approx INR 600 crore via its first ever QIP; Issue oversubscribed by 6.5x21 Sep 2026 · Company Update / Press Release / Media Release
Intimation of Analyst/Investor meeting to be held on September 22, 2026.17 Sep 2026 · Company Update / Analyst / Investor Meet
Outcome of Fund raising Committee meeting approving allotment of equity shares on QIP basis.17 Sep 2026 · Company Update / General
Outcome of fund raising committee approving allotment of equity shares on QIP basis.17 Sep 2026 · Company Update / Allotment of Equity Shares
Outcome of Fund raising committee approving allotment of equity shares on QIP basis17 Sep 2026 · Company Update / Qualified Institutional Placement
Outcome of Fund raising committee held today approving closure of issue, issue price, placement document, and confirmation of allocation note16 Sep 2026 · Company Update / General
Outcome of Fund Raising Committee held today approving closure of issue, issue price, placement document and confirmation of allocation note.16 Sep 2026 · Company Update / Qualified Institutional Placement
Approval of Issue opening date and Floor price and PPD.10 Sep 2026 · Company Update / General
Outcome of Fund raising committee meeting held today for opening of QIP issue.10 Sep 2026 · Company Update / Qualified Institutional Placement
Show Cause cum Demand Notice received from Office of the Commissioner CGST.6 Sep 2026 · Company Update / General
Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.31 Aug 2026 · Company Update / General
Disclosure pursuant to regulation 7(2) of SEBI PIT Regulations.29 Aug 2026 · Company Update / General
Submission of Consolidated Voting Results and Scrutinizer''s Report of the 37th AGM.22 Aug 2026 · Company Update / General
Consolidated Voting Results and Scrutinizer''s Report of the 37th AGM.22 Aug 2026 · AGM/EGM / AGM
Proceedings of the 37th AGM.21 Aug 2026 · AGM/EGM / AGM
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund20 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund20 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Earnings Call Transcript - Q1FY271 Aug 2026 · Company Update / Earnings Call Transcript
Notice of 37th AGM to be held on 21-08-2026 in newspaper publication.30 Jul 2026 · Company Update / Newspaper Publication
Intimation of book closure period and record date for 37th AGM to be held on 21-08-2026.30 Jul 2026 · Corp. Action / Book Closure
BRSR and BRSR Assurance Report FY 2025-26.30 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.0000	13 Aug 2026	13 Aug 2026	—
Final Dividend - Rs. - 1.0000	19 Sep 2025	19 Sep 2025	—
Final Dividend - Rs. - 2.0000	19 Sep 2024	—	—

Board meetings

31 Oct 2026 Board Meeting - Financial Results
24 Jul 2026 Board Meeting - Financial Results